Caricamento...
Antiviral treatment for COVID-19: the evidence supporting remdesivir
The emergence of the novel beta coronavirus SARS-CoV-2 and the ensuing COVID-19 pandemic has generated a rapidly evolving research landscape in the search for new therapeutic agents. The intravenous antiviral drug remdesivir has in vitro activity against SARS-CoV-2 and now studies have reported its...
Salvato in:
| Pubblicato in: | Clin Med (Lond) |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Royal College of Physicians
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7687338/ https://ncbi.nlm.nih.gov/pubmed/32863273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmed.2020-0524 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|